{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:35:25Z","timestamp":1789990525925,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,11,16]],"date-time":"2012-11-16T00:00:00Z","timestamp":1353024000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00431-012-1893-3","type":"journal-article","created":{"date-parts":[[2012,11,15]],"date-time":"2012-11-15T10:23:18Z","timestamp":1352974998000},"page":"351-356","source":"Crossref","is-referenced-by-count":128,"title":["Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt"],"prefix":"10.1007","volume":"172","author":[{"given":"Mohamed A.","family":"El-Khalawany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Ghonaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayoumi","family":"Eassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,16]]},"reference":[{"key":"1893_CR1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jaci.2006.03.045","volume":"118","author":"CA Akdis","year":"2006","unstructured":"Akdis CA, Akdis M, Biber T, Bindslev-Jensen C, Boquniewicz M, Eigenmann P, European Academy of Allergology, Clinical Immunology\/American Academy of Allergy, Asthma And Immunology\/PRACTALL Consensus Group (2006) Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology\/American Academy of Allergy, Asthma and Immunology\/PRACTALL Consensus Report. J Allergy Clin Immunol 118:152\u2013169","journal-title":"J Allergy Clin Immunol"},{"key":"1893_CR2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1365-2230.2005.01766.x","volume":"30","author":"P Balasubramaniam","year":"2005","unstructured":"Balasubramaniam P, Ilchyshyn A (2005) Successful treatment of severe atopic dermatitis with methotrexate. Clin Exp Dermatol 30:436\u2013440","journal-title":"Clin Exp Dermatol"},{"key":"1893_CR3","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/j.1365-2133.2007.07879.x","volume":"156","author":"EA Bateman","year":"2007","unstructured":"Bateman EA, Ardern-Jones M, Ogg GS (2007) Dose-related reduction in allergen-specific T cells associates with clinical response of atopic dermatitis to methotrexate. Br J Dermatol 156:1376\u20131377","journal-title":"Br J Dermatol"},{"key":"1893_CR4","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0190-9622(96)90281-9","volume":"34","author":"J Berth-Jones","year":"1996","unstructured":"Berth-Jones J, Finlay AY, Zaki I, Tan B, Goodyear H, Lewis-Jones S, Cork MJ, Bleehen SS, Salek MS, Allen BR, Smith S, Graham-Brown RA (1996) Cyclosporin in severe childhood atopic dermatitis: a multicenter study. J Am Acad Dermatol 34:1016\u20131021","journal-title":"J Am Acad Dermatol"},{"key":"1893_CR5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1034\/j.1399-3038.2001.012004216.x","volume":"12","author":"R Bunikowski","year":"2001","unstructured":"Bunikowski R, Staab D, Kussebi F, Br\u00e4utigam M, Weidinger G, Renz H, Wahn U (2001) Low-dose cyclosporin a microemulsion in children with severe atopic dermatitis: clinical and immunological effects. Pediatr Allergy Immunol 12:216\u2013223","journal-title":"Pediatr Allergy Immunol"},{"key":"1893_CR6","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000024346","volume":"121","author":"M Caproni","year":"2000","unstructured":"Caproni M, Salvatore E, Cardinali C, Brazzini B, Fabbri P (2000) Soluble CD30 and cyclosporin in severe atopic dermatitis. Int Arch Allergy Immunol 121:324\u2013328","journal-title":"Int Arch Allergy Immunol"},{"key":"1893_CR7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2230.2008.02907.x","volume":"34","author":"B Collin","year":"2009","unstructured":"Collin B, Vani A, Ogboli M, Moss C (2009) Methotrexate treatment in 13 children with severe plaque psoriasis. Clin Exp Dermatol 34:295\u2013298","journal-title":"Clin Exp Dermatol"},{"key":"1893_CR8","first-page":"129","volume":"49","author":"MA Cordero Miranda","year":"2002","unstructured":"Cordero Miranda MA, Casas Becerra B, Reyes Ruiz NI, Avila Casta\u00f1\u00f3n L, del R\u00edo Navarro BE, Sienra Monge JJ (2002) Cyclosporin A in atopic dermatitis. Rev Alerg Mex 49:129\u2013134","journal-title":"Rev Alerg Mex"},{"key":"1893_CR9","first-page":"155","volume":"16","author":"C Goujon","year":"2006","unstructured":"Goujon C, B\u00e9rard F, Dahel K, Guillot I, Hennino A, Nosbaum A, Saad N, Nicolas JF (2006) Methotrexate for the treatment of adult atopic dermatitis. Eur J Dermatol 16:155\u2013158","journal-title":"Eur J Dermatol"},{"key":"1893_CR10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2133.2000.03241.x","volume":"142","author":"JI Harper","year":"2000","unstructured":"Harper JI, Ahmed I, Barclay G, Lacour M, Hoeger P, Cork MJ, Finlay AY, Wilson NJ, Graham-Brown RA, Sowden JM, Beard AL, Sumner MJ, Berth-Jones J (2000) Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol 142:52\u201358","journal-title":"Br J Dermatol"},{"key":"1893_CR11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1525-1470.2008.00629.x","volume":"25","author":"I Kaur","year":"2008","unstructured":"Kaur I, Dogra S, De D, Kanwar AJ (2008) Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India. Pediatr Dermatol 25:184\u2013188","journal-title":"Pediatr Dermatol"},{"key":"1893_CR12","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000245677","volume":"195","author":"B Kunz","year":"1997","unstructured":"Kunz B, Oranje AP, Labr\u00e8ze L, Stalder JF, Ring J, Ta\u00efeb A (1997) Clinical validation and guidelines for the SCORAD index: consensus report of the European task force on atopic dermatitis. Dermatology 195:10\u201319","journal-title":"Dermatology"},{"key":"1893_CR13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.47102\/annals-acadmedsg.V33N3p311","volume":"33","author":"SS Lee","year":"2004","unstructured":"Lee SS, Tan AW, Giam YC (2004) Cyclosporin in the treatment of severe atopic dermatitis: a retrospective study. Ann Acad Med Singapore 33:311\u2013313","journal-title":"Ann Acad Med Singapore"},{"key":"1893_CR14","first-page":"231","volume":"56","author":"S Leonardi","year":"2004","unstructured":"Leonardi S, Marchese G, Rotolo N, Miraglia Del Giudice M, La Rosa M (2004) Cyclosporin is safe and effective in severe atopic dermatitis of childhood. Report of three cases. Minerva Pediatr 56:231\u2013237","journal-title":"Minerva Pediatr"},{"key":"1893_CR15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0140-6736(03)12193-9","volume":"361","author":"DY Leung","year":"2003","unstructured":"Leung DY, Bieber T (2003) Atopic dermatitis. Lancet 361:151\u2013160","journal-title":"Lancet"},{"key":"1893_CR16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2177\/jsci.20.178","volume":"20","author":"S Nakata","year":"1997","unstructured":"Nakata S, Uematsu K, Mori T, Mitsushita N, Kinoshita T, Ishioka C, Mutou K, Yokota S, Hirose Y, Komiyama A (1997) Effective treatment with low-dose methotrexate pulses of a child of mixed connective tissue disease with severe myositis refractory to corticosteroid. Nihon Rinsho Meneki Gakkai Kaishi 20:178\u2013183","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"1893_CR17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1440-0960.2010.00634.x","volume":"51","author":"H Roberts","year":"2010","unstructured":"Roberts H, Orchard D (2010) Methotrexate is a safe and effective treatment for paediatric discoid (nummular) eczema: a case series of 25 children. Australas J Dermatol 51:128\u2013130","journal-title":"Australas J Dermatol"},{"key":"1893_CR18","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1468-3083.2006.02023.x","volume":"21","author":"J Schmitt","year":"2007","unstructured":"Schmitt J, Schmitt N, Meurer M (2007) Cyclosporin in the treatment of patients with atopic eczema\u2014a systematic review and meta-analysis. J Eur Acad Dermatol Venereol 21:606\u2013619","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1893_CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0140-6736(91)90134-B","volume":"338","author":"JM Sowden","year":"1991","unstructured":"Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY, Salek MS, Graham-Brown RA, Allen BR, Camp RD (1991) Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 338:137\u2013140","journal-title":"Lancet"},{"key":"1893_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/adc.76.2.159","volume":"76","author":"JC Su","year":"1997","unstructured":"Su JC, Kemp AS, Varigos GA, Nolan TM (1997) Atopic eczema: its impact on the family and financial cost. Arch Dis Child 76:159\u2013162","journal-title":"Arch Dis Child"},{"key":"1893_CR21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2133.2006.07686.x","volume":"156","author":"SC Weatherhead","year":"2007","unstructured":"Weatherhead SC, Wahie S, Reynolds NJ, Meggitt SJ (2007) An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema. Br J Dermatol 156:346\u2013351","journal-title":"Br J Dermatol"},{"key":"1893_CR22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1365-2133.2006.07497.x","volume":"155","author":"L Weibel","year":"2006","unstructured":"Weibel L, Sampaio MC, Visentin MT, Howell KJ, Woo P, Harper JI (2006) Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children. Br J Dermatol 155:1013\u20131020","journal-title":"Br J Dermatol"},{"key":"1893_CR23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0091-6749(99)70536-1","volume":"103","author":"H Williams","year":"1999","unstructured":"Williams H, Robertson C, Stewart A, Ait-Khaled N, Anabwani G, Anderson R (1999) Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood. J Allergy Clin Immunol 103:125\u2013138","journal-title":"J Allergy Clin Immunol"},{"key":"1893_CR24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1440-0960.2010.00734.x","volume":"52","author":"L Yip","year":"2011","unstructured":"Yip L, Darling S, Orchard D (2011) Lymphomatoid papulosis in children: experience of five cases and the treatment efficacy of methotrexate. Australas J Dermatol 52:279\u2013283","journal-title":"Australas J Dermatol"},{"key":"1893_CR25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-2133.1996.tb00705.x","volume":"135","author":"I Zaki","year":"1996","unstructured":"Zaki I, Emerson R, Allen BR (1996) Treatment of severe atopic dermatitis in childhood with cyclosporin. Br J Dermatol 135:21\u201324","journal-title":"Br J Dermatol"},{"key":"1893_CR26","first-page":"413","volume":"10","author":"L Zoller","year":"2008","unstructured":"Zoller L, Ramon M, Bergman R (2008) Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema. Isr Med Assoc J 10:413\u2013414","journal-title":"Isr Med Assoc J"},{"key":"1893_CR27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2133.1996.tb00704.x","volume":"135","author":"IM Zonneveld","year":"1996","unstructured":"Zonneveld IM, De Rie MA, Beljaards RC, Van Der Rhee HJ, Wuite J, Zeegelaar J, Bos JD (1996) The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: a comparison of two dosage regimens. Br J Dermatol 135:15\u201320","journal-title":"Br J Dermatol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-012-1893-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-012-1893-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-012-1893-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T11:25:53Z","timestamp":1714562753000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-012-1893-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,16]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["1893"],"URL":"https:\/\/doi.org\/10.1007\/s00431-012-1893-3","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,16]]}}}